CIK 0000886163 · Large accelerated filer
LIGAND PHARMACEUTICALS INC
Sign in to watch- Tickers
- LGND LGNDZ LGNXZ LGNYZ LGNZZ
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 770160744
- Phone
- 858-550-7500
- Business address
- 3911 SORRENTO VALLEY BLVD, SUITE 110, SAN DIEGO, CA, 92121
- Former names
- LIGAND PHARMACEUTICALS
Securities
- LGND Common Stock Nasdaq
- LGNDZ Common stock OTC
- LGNXZ Common stock OTC
- LGNYZ Common stock OTC
- LGNZZ Common stock OTC
- 8-K Event Material agreement
- 425 Deal Prospectus/Communication re Business Combination
- UPLOAD Other SEC-generated Letter
- 8-K Event Material agreement
- CT ORDER Other Confidential Order
- S-4 Deal Registration Statement - Business Combination
- 8-K Event Other events
- 425 Deal Prospectus/Communication re Business Combination
- 425 Deal Prospectus/Communication re Business Combination
- 8-K Event Regulation FD disclosure
- SC 13D Stake Beneficial Ownership Report
- 8-K Event Other events
- 425 Deal Prospectus/Communication re Business Combination
- 424B3 Offering Prospectus
- 425 Deal Prospectus/Communication re Business Combination
- 8-K Event Agreement ended
- 10-Q Report Quarterly Report
- EFFECT Other Notice of Effectiveness
- 425 Deal Prospectus/Communication re Business Combination
- 8-K Event Material agreement
Page 77 of 115 · 2,300 filings